1
|
Tahirli S, Aliyeva F, Şenol H, Demukhamedova S, Akverdieva G, Aliyeva I, Veysova S, Sadeghian N, Günay S, Erden Y, Taslimi P, Sujayev A, Chiragov F. Novel complex compounds of nickel with 3-(1-phenyl-2,3-dimethyl-pyrazolone-5)azopentadione-2,4: synthesis, NBO analysis, reactivity descriptors and in silico and in vitro anti-cancer and bioactivity studies. J Biomol Struct Dyn 2024:1-25. [PMID: 38294759 DOI: 10.1080/07391102.2024.2309646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Accepted: 01/18/2024] [Indexed: 02/01/2024]
Abstract
A synthesized azo compound based on 4-amino antipyrine and its complexes with Ni(II) in solution and solid phase is reported. The structures of these compounds have been testified by IR and NMR spectroscopy. The combined experimental and theoretical approach was used. To study the structure and properties of the synthesized compound, as well as its possible complex formation with the Ni(II), ab initio quantum-chemical calculations were carried out using the Hartree-Fock (HF) method with the 6-31 G basis set and the electron density functional theory (DFT) method with hybrid three-parameter potential B3LYP and extended basis set 6-311++G(d,p) taking into account polarization and diffuse functions for all atoms. The geometric, energy, and electronic parameters were calculated and analyzed. The HOMO-LUMO energy gap has been calculated to determine chemical activity. Both complexes had effective inhibition against butyrylcholinesterase and acetylcholinesterase. IC50 values were found as 19.43 and 27.08 µM for AChE, 2.37 and 7.40 µM for BChE, respectively. For the anticancer outcome, high doses of compound E1 inhibited viability by about 40-45%, while this rate was around 65-70% for compound E2 at the same doses. Anticholinesterase and anticancer potential of compounds E1 and E2 also evaluated by in silico techniques. Both compounds show strong binding to VEGFR1, with E2 exhibiting superior inhibitory activity in hAChE and hBChE through shorter and stronger interactions. MD simulations suggest that E2 forms more stable complexes with hAChE and hBChE compared to E1, making it a promising candidate for further exploration in anticancer and anticholinesterase therapies.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
| | - Fargana Aliyeva
- Institute of Chemistry of Additives named after acad. A. M. Guliyev, Baku, Azerbaijan
| | - Halil Şenol
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Bezmialem Vakif University, Fatih, Istanbul, Türkiye
| | | | - Gulnara Akverdieva
- Institute for Physical Problems, Baku State University, Baku, Azerbaijan
| | - Irada Aliyeva
- Institute for Physical Problems, Baku State University, Baku, Azerbaijan
| | | | - Nastaran Sadeghian
- Faculty of Science, Department of Biotechnology, Bartın University, Bartın, Türkiye
| | - Sevilay Günay
- Faculty of Science, Department of Molecular Biology and Genetics, Bartın University, Bartın, Türkiye
| | - Yavuz Erden
- Faculty of Science, Department of Molecular Biology and Genetics, Bartın University, Bartın, Türkiye
| | - Parham Taslimi
- Faculty of Science, Department of Biotechnology, Bartın University, Bartın, Türkiye
| | - Afsun Sujayev
- Institute of Chemistry of Additives named after acad. A. M. Guliyev, Baku, Azerbaijan
| | | |
Collapse
|
2
|
Tokalı FS, Şenol H, Yetke Hİ, Hacıosmanoğlu-Aldoğan E. Novel quinazoline-chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies. Arch Pharm (Weinheim) 2023; 356:e2300423. [PMID: 37736677 DOI: 10.1002/ardp.202300423] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 08/31/2023] [Accepted: 09/02/2023] [Indexed: 09/23/2023]
Abstract
In this study, new quinazoline-chromene hybrid compounds were synthesized. The cytotoxic effects on cell viability of the hybrid compounds were tested against A549 human lung adenocarcinoma and BEAS-2B healthy bronchial epithelial cell lines in vitro. In addition, the ability of the active compounds to inhibit cell migration was tested. Molecular docking studies were performed to evaluate the ligand-protein interactions, and molecular dynamics simulations were performed to determine the interactions and stability of ligand-protein complexes. In silico absorption, distribution, metabolism, and excretion (ADME) studies were conducted to estimate the drug-likeness of the compounds. Compounds 4 (IC50 = 51.2 µM) and 5 (IC50 = 44.2 µM) were found to be the most active agents against A549 cells. They are found to be more selective against A549 cells than the reference drug doxorubicin. They also have the ability to significantly inhibit cell migration. They have the best docking scores against epidermal growth factor receptor (EGFR) (-11.300 and -11.226 kcal/mol) and vascular endothelial growth factor receptor 2 (VEGFR2) (-10.987 and -11.247 kcal/mol), respectively. In MD simulations, compounds 4 and 5 have strong hydrogen bond interactions above 80% of simulation times and showed a low ligand root mean square deviation (RMSD) around 2 Å. According to the ADME analysis, compounds 4 and 5 exhibit excellent drug-likeness and pharmacokinetic characteristics.
Collapse
Affiliation(s)
- Feyzi Sinan Tokalı
- Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Türkiye
| | - Halil Şenol
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, Fatih, Istanbul, Türkiye
| | - Hande İpek Yetke
- Department of Biophysics, Faculty of Medicine, Bezmialem Vakif University, Fatih, Istanbul, Türkiye
| | | |
Collapse
|
3
|
ALİM TORAMAN GÖ, ŞENOL H, YAZICI TÜTÜNİŞ S, TAN N, TOPÇU G. Phytochemical analysis and molecular docking studies of two endemic varieties of Salvia sericeotomentosa. Turk J Chem 2023; 47:1260-1270. [PMID: 38173760 PMCID: PMC10760817 DOI: 10.55730/1300-0527.3610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 10/31/2023] [Accepted: 09/30/2023] [Indexed: 01/05/2024] Open
Abstract
The use of medicinal plants for treating various diseases dates back thousands of years and has been a part of many cultures around the world. Various parts of plants, including roots, leaves, and flowers, and their extracts have been used to develop remedies to cure different ailments like fever, pain, inflammation, infections, among others. In this research, the aerial parts of both Salvia varieties were extracted with ethanol and water to obtain infusion and decoction, separately. S. sericeotomentosa var. hatayica Celep & Doğan (SH) and Salvia sericeotomentosa Rech. f. var. sericeotomentosa (ST) plants were chemically analyzed for polar compounds using LC-HRMS for the first time. All SH and ST extracts were found to be very rich in rosmarinic acid, salvianolic acid B, hispidulin-7-O-glucoside, and caffeic acid. The study also investigated the antiinflammatory and carbonic anhydrase inhibition properties of the most abundant secondary metabolites extracted from SH and ST. In silico studies were conducted for the first time to explore the effects of these metabolites on TNF-α, iNOS, and human carbonic anhydrase isoenzymes (hCAI and hCAII). Salvianolic acid B should be considered a strong antiinflammatory agent and a carbonic anhydrase I and II inhibitors due to low binding energy scores with the tested enzymes (TNF-α: -12.391 kcal/mol), (iNOS: -7.547 kcal/mol), (hCAI: -7.877 kcal/mol), and (hCAII: -4.312 kcal/mol).
Collapse
Affiliation(s)
- Gülbahar Özge ALİM TORAMAN
- Department of Pharmacognosy, Faculty of Pharmacy, Bezmiâlem Vakıf University, İstanbul,
Turkiye
- Department of Pharmacognosy, Faculty of Pharmacy, İstanbul University, İstanbul,
Turkiye
- Department of Pharmacognosy, Institute of Health Sciences, İstanbul University, İstanbul,
Turkiye
| | - Halil ŞENOL
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmiâlem Vakıf University, İstanbul,
Turkiye
| | - Seçil YAZICI TÜTÜNİŞ
- Department of Pharmacognosy, Faculty of Pharmacy, İstanbul University, İstanbul,
Turkiye
- Center for Research and Practice in Drug Development from Natural Sources, İstanbul University, İstanbul,
Turkiye
| | - Nur TAN
- Department of Pharmacognosy, Faculty of Pharmacy, İstanbul University, İstanbul,
Turkiye
- Center for Research and Practice in Drug Development from Natural Sources, İstanbul University, İstanbul,
Turkiye
| | - Gülaçtı TOPÇU
- Department of Pharmacognosy, Faculty of Pharmacy, Bezmiâlem Vakıf University, İstanbul,
Turkiye
- Drug Application and Research Center (DARC), Bezmiâlem Vakif University, İstanbul,
Turkiye
| |
Collapse
|
4
|
Şenol H, Ghaffari-Moghaddam M, Bulut Ş, Akbaş F, Köse A, Topçu G. Synthesis and Anticancer Activity of Novel Derivatives of α,β-Unsaturated Ketones Based on Oleanolic Acid: in Vitro and in Silico Studies against Prostate Cancer Cells. Chem Biodivers 2023; 20:e202301089. [PMID: 37596247 DOI: 10.1002/cbdv.202301089] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 08/16/2023] [Accepted: 08/18/2023] [Indexed: 08/20/2023]
Abstract
Herein, new derivatives of α,β-unsaturated ketones based on oleanolic acid (4 a-i) were designed, synthesized, characterized, and tested against human prostate cancer (PC3). According to the in vitro cytotoxic study, title compounds (4 a-i) showed significantly lower toxicity toward healthy cells (HUVEC) in comparison with the reference drug doxorubicin. The compounds with the lowest IC50 values on PC3 cell lines were 4 b (7.785 μM), 4 c (8.869 μM), and 4 e (8.765 μM). The results of the ADME calculations showed that the drug-likeness parameters were within the defined ranges according to Lipinski's and Jorgensen's rules. For the most potent compounds 4 b, 4 c, and 4 e, a molecular docking analysis using the induced fit docking (IFD) protocol was performed against three protein targets (PARP, PI3K, and mTOR). Based on the IFD scores, compound 4 b had the highest calculated affinity for PARP1, while compound 4 c had higher affinities for mTOR and PI3K. The MM-GBSA calculations showed that the most potent compounds had high binding affinities and formed stable complexes with the protein targets. Finally, a 50 ns molecular dynamics simulation was performed to study the behavior of protein target complexes under in silico physiological conditions.
Collapse
Affiliation(s)
- Halil Şenol
- Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34093 Fatih, Istanbul, Türkiye
| | - Mansour Ghaffari-Moghaddam
- Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34093 Fatih, Istanbul, Türkiye
- University of Zabol, Faculty of Science, Department of Chemistry, Zabol, 98615-538, Iran
| | - Şeyma Bulut
- Bezmialem Vakif University, Institute of Health Sciences, Department of Biotechnology, 34093 Fatih, Istanbul, Türkiye
- Bezmialem Vakif University, Faculty of Medicine, Department of Medical Biology, 34093 Fatih, Istanbul, Türkiye
| | - Fahri Akbaş
- Bezmialem Vakif University, Faculty of Medicine, Department of Medical Biology, 34093 Fatih, Istanbul, Türkiye
| | - Aytekin Köse
- Aksaray University, Faculty of Science and Letters, Department of Chemistry, 68100, Aksaray, Türkiye
| | - Gülaçtı Topçu
- Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmacognosy & Phytochemistry Chemistry, 34093 Fatih, Istanbul, Türkiye
| |
Collapse
|